Key result
Chinese women with T2DM had a lower predicted 10-year CHD risk compared to men, while metabolic syndrome increased CHD risk in both sexes.
Why the study?
Does gender and the presence of metabolic syndrome affect the predicted 10-year risks of coronary heart disease and stroke in Chinese patients with type 2 diabetes mellitus?
Cross-Sectional (n=1,514)
No
Does gender and the presence of metabolic syndrome affect the predicted 10-year risks of coronary heart disease and stroke in Chinese patients with type 2 diabetes mellitus?
Chinese women with type 2 diabetes have lower predicted 10-year risks of CHD and stroke than men, but comorbid metabolic syndrome substantially elevates cardiovascular and cerebrovascular risk across both sexes, underscoring the need for comprehensive metabolic control.
Answers are grounded in this paper and cite their sources.
Supports sex-specific CHD risk prediction in Chinese T2DM; hypothesis-generating for metabolic syndrome effects, requiring prospective validation.
Coronary heart disease (CHD) and stroke are common complications of type 2 diabetes mellitus (T2DM). We aimed to explore the differences in the risks of CHD and stroke between Chinese women and men with T2DM and their association with metabolic syndrome (MS). This study included 1514 patients with T2DM. The Asian Guidelines of ATPIII (2005) were used for MS diagnosis, and the UKPDS risk engine was used to evaluate the 10-year CHD and stroke risks. Women had lower CHD risk (15.3% versus 26.3%), fatal CHD risk (11.8% versus 19.0%), stroke risk (8.4% versus 10.3%), and fatal stroke risk (1.4% versus 1.6%) compared with men with T2DM (p<0.05–0.001). The CHD risk (28.4% versus 22.6%, p<0.001) was significantly higher in men with MS than in those without MS. The CHD (16.2% versus 11.0%, p<0.001) and stroke risks (8.9% versus 5.8%, p<0.001) were higher in women with MS than in those without MS. In conclusion, our findings indicated that Chinese women with T2DM are less susceptible to CHD and stroke than men. Further, MS increases the risk of both these events, highlighting the need for comprehensive metabolic control in T2DM.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2016) conducted a cross-sectional in Type 2 diabetes mellitus (T2DM) (n=1,514). Female sex (and presence of metabolic syndrome) vs. Male sex (and absence of metabolic syndrome) was evaluated on Predicted 10-year coronary heart disease (CHD) risk evaluated by the UKPDS risk engine (p=<0.001). Chinese women with T2DM had a lower predicted 10-year CHD risk compared to men, while metabolic syndrome increased CHD risk in both sexes.
Synapse has enriched 10 related papers. Consider them for comparative context: